With $55 billion earmarked to bolster its U.S. operations, Johnson & Johnson is the latest drugmaker to zero in on expansion ...

Johnson & Johnson, the healthcare and lifestyle giant announced a more than $1 billion dollar investment in next generation ...

As the CGT market evolves, developers must answer one key question that will shape their manufacturing strategy: “Should we go with a modular platform or a fully integrated system?”  Both approaches ...

Once fully operational, the Pennsylvania site will employ more than 500 people and make cell therapies for thousands of patients a year.

Biotechnology company Bracco Imaging announced its expansion into the cell-therapy manufacturing space, establishing a new application for its microbubble technology, which is designed to offer a bead ...

At the 2024 annual meeting of the International Society for Cell & Gene Therapy (ISCT) in Vancouver, Canada, Hélio Tomás, PhD, senior research associate at the Instituto de Biologia Experimental e ...

Adoptive therapies based on CAR/TCR T cells—that is, T cells with an engineered chimeric antigen receptor (CAR) or a T-cell receptor (TCR)—have shown promise for a range of cancers, offering hope to ...